Katherine Bourzac. Show Affiliations »
Abstract
Mesh: See more » Antineoplastic Combined Chemotherapy ProtocolsBenzamides/therapeutic useBiological EvolutionDrug Resistance, Neoplasm/drug effectsDrug Resistance, Neoplasm/geneticsGenes, Tumor SuppressorHumansImatinib MesylateImmunity/drug effectsLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyLeukemia, Myelogenous, Chronic, BCR-ABL Positive/geneticsLeukemia, Myelogenous, Chronic, BCR-ABL Positive/pathologyNeoplasm Metastasis/geneticsNeoplasm Metastasis/pathologyNeoplasms/drug therapyNeoplasms/geneticsNeoplasms/immunologyNeoplasms/pathologyPiperazines/therapeutic usePyrimidines/therapeutic useTumor Microenvironment/drug effectsTumor Microenvironment/genetics
Substances: See more » BenzamidesPiperazinesPyrimidinesImatinib Mesylate
Year: 2014 PMID: 24870828 DOI: 10.1038/509S69a
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962